Fund profile

ISIN DE000A2AQYV6
WKN A2AQYV
Inception date
Total fund assets 124.3 M EUR
Share class currency EUR
Current issue price EUR12,998.06 (12/16/2025)
Current return price EUR12,998.06 (12/16/2025)
Annual high (redemption price) EUR15,467.74 (02/19/2025)
Annual low (redemption price) EUR11,823.61 (04/22/2025)
Performance current year -9.25 % (12/16/2025)
ø Performance
Since launch p.a.
3.29 % (12/16/2025)
Issue charge 0.00 %
Redemption charge 0.00 %
End of fiscal year May 31
Dividend Payout
Total expense ratio 0.85 % p.a.
Management fee   therefrom 0.77 % p.a.
Custodian fee   therefrom 0.06 % p.a.
Capital accumulation benefits capable no
Savings plan no
Single payment yes (min EUR500,000.00)
Conformity yes
Registered for distribution DE , AT

Key figures

Percentage of assets invested 95.98 %
Liquidity ratio 1
VaR 7.97 %
Duration of loss in days 300
Sharpe ratio -0.32
Volatility 16.32 %
Max. drawdown -23.56 %
Drawdown -15.97 %
Number of negative months 16
Number of positive months 20
Share of positive months 55.56 %
Worst month -9.65 %
Best month 9.22 %

Comment

Healthcare stocks continued the positive momentum of previous months in November and rose significantly. The sector closed the reporting month as the strongest sector in the S&P 500 and has now fully recovered from the sell-off in the first half of the year. In the reporting season that is now coming to an end, the majority of companies confirmed their growth outlook and indicated that the fundamental environment remains intact. At the same time, M&A activity increased, particularly in the biotechnology sector, further underscoring the structural interest in the sector. In November, stocks from the "Life Science & Tools" sector made a particularly positive contribution to performance. On the negative side, technology-oriented companies declined, weighing on fund performance.

11/30/2025

Opportunities

  • Participation in the transformation of the global healthcare market
  • Focus on innovative technologies and services
  • Thematically flexible and adaptable
  • Broad diversification across companies with disruptive potential
  • Experienced and specialized fund management team

Risks

  • Market and sector risks
  • Credit risks
  • Counterparty risks
  • Currency risks
  • In general, any investment carries the risk of capital loss
  • Information on further risks can be found in the Basisinformationsblatt and the VKP .

This is detail text.